CRISPR Based Technologies and Bio-products

Genome piece of writing and also the utilization of CRISPR based technologies are expected to revolutionize the assembly of succeeding generation of bio product. DCB12 will concentrate on the foremost recent developments among the employment of CRISPR/Cas9 and different CRISPR based technologies in relevance the event and production of biopharmaceuticals, biochemical, agricultural crops and travel applications. The global market for genetic modification therapies should grow from $2.3 billion in 2018 to reach $17.4 billion by 2023, growing at a compound annual growth rate (CAGR) of 49.9% during the forecast period of 2018-2023.

    Related Conference of CRISPR Based Technologies and Bio-products

    February 24-25, 2025

    19th International Conference on Regenerative Repair and Medicine

    Madrid, Spain
    April 03-04, 2025

    15th International Conference on Human Genetics and Genetic Diseases

    Madrid, Spain
    April 03-04, 2025

    18th International Conference on Genomics & Pharmacogenomics

    Madrid, Spain
    April 14-15, 2025

    8th Annual Conference on Stem Cell and Regenerative Medicine

    Budapest, Hungary
    April 29-30, 2025

    3rd International Conference on Cell Science and Molecular Biology

    Barcelona, Spain
    May 19-20, 2025

    8th Global Conference on Cell and Gene Therapy

    Singapore City, Singapore
    June 12-13, 2025

    13th World Congress on Human Genetics and Genetic Diseases

    London, UK
    June 16-17, 2025

    21st Global Summit on Stem Cell & Regenerative Medicine

    Frankfurt, Germany
    July 21-22, 2025

    18th World Congress on Stem Cell Research

    Barcelona, Spain
    October 27-28, 2025

    20th World Congress on Tissue Engineering Regenerative Medicine and Stem Cell Research

    Madrid, Spain

    CRISPR Based Technologies and Bio-products Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in